Inve India ▾
ROROSSARI

Rossari Biotech Q2 FY25 results (Jul–Sep 2024) and concall

Chemicals · Concall AI · Call held 21 Oct 2024

Company page: Rossari Biotech share price, financials & guidance record

Source transcript

Rossari Biotech reported a steady Q2 FY25 performance with 3% YoY revenue growth, driven by strong export performance and HPPC division. Despite headwinds in the Textile segment and softer domestic growth, gross margins expanded significantly. The company is strategically focusing on global expansion and capacity enhancements, with several CAPEX projects underway to support future growth and improve return ratios.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.